Peter F Coccia MD

Pediatric Hematology & Oncology•Omaha, NE

Pediatric Hematologic Oncology

Professor of Pediatrics, University Nebr College of Medicine

Join to View Full Profile

988102 Nebraska Medical CtrOmaha, NE 68198
Phone+1 402-559-7257
Fax+1 402-559-6782

Education & Training

University of MinnesotaResidency, Pediatrics, 1972 - 1974
SUNY Upstate Medical UniversityResidency, Pathology-Anatomic and Clinical, 1968 - 1970
SUNY Upstate Medical UniversityClass of 1968

Certifications & Licensure

NE State Medical License 1987 - 2026
OH State Medical License 1980 - 1988
MN State Medical License 1972 - 1980
American Board of Pathology Clinical Pathology
American Board of Pathology Hematology
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2007-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
ACTIVE_NOT_RECRUITING
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
ACTIVE_NOT_RECRUITING
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
ACTIVE_NOT_RECRUITING
PHASE3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
ACTIVE_NOT_RECRUITING
PHASE3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
ACTIVE_NOT_RECRUITING
PHASE3
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
ACTIVE_NOT_RECRUITING
PHASE3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
COMPLETED
PHASE3
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
ACTIVE_NOT_RECRUITING
PHASE3
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

121 citations
Acute lymphoblastic leukemia, version 2.2021
Patrick A. Brown, Bijal D. Shah, Anjali S. Advani, Patricia Aoun, Michael Boyer
Journal of the National Comprehensive Cancer Network. 2021-09-01
4 citations
RE: A Reappraisal of Sex-Specific Cancer Survival Trends Among Adolescents and Young Adults in the United States.
Stuart E. Siegel, Peter F. Coccia, Ronald D. Barr, Brandon Hayes-Lattin, Archie Bleyer
Journal of the National Cancer Institute. 2019-06-01
39 citations
Acute lymphoblastic leukemia, version 1.2019 featured updates to the NCCN guidelines
Patrick A. Brown, Matthew J. Wieduwilt, Aaron C Logan, Daniel J. DeAngelo, Eunice S. Wang
Journal of the National Comprehensive Cancer Network. 2019-05-01